Oral Solid Dosage Contract Manufacturing Market: Regulatory Changes Impacting Growth
The global oral solid dosage (OSD) contract manufacturing market was valued at USD 36.50 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 5.97% from 2024 to 2030. The market's growth is fueled by advancements in drug delivery technologies, including targeted drug delivery and sustained-release dosage forms. Additionally, contract development manufacturing...
0 Comments 0 Shares 122 Views 0 Reviews
Sponsored